17:04 EDT Rein Therapeutics (RNTX) files to sell 10M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNTX:
- Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
- Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
- Rein Therapeutics Gains Approval for Phase 2 Trial
- Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
- Rein Therapeutics downgraded to Hold from Buy at Brookline